| Literature DB >> 23705639 |
Patrick C Hardigan1, David C Schwartz, William D Hardigan.
Abstract
BACKGROUND: Falls among the elderly are a major public health concern. Therefore, the possibility of a modeling technique which could better estimate fall probability is both timely and needed. Using biomedical, pharmacological and demographic variables as predictors, latent class analysis (LCA) is demonstrated as a tool for the prediction of falls among community dwelling elderly.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23705639 PMCID: PMC3673854 DOI: 10.1186/1472-6947-13-60
Source DB: PubMed Journal: BMC Med Inform Decis Mak ISSN: 1472-6947 Impact factor: 2.796
Figure 1Proposed fall model for the latent class analysis. Yi are the observed categorical medical indicators on the latent classes C. Drug Measure is the correspondence analysis derived drug score for each subject. Age is the age of patient. # Rx is the number of prescriptions taken by each subject. Gender is the subjects reported gender. Falling is the distal outcome.
Descriptive statistics
| Age | Mean ± SD | 77.47 ± 6.91 | 77.98 ± 7.41 |
| Number of Medications | Mean ± SD | 2.30 ± 5.57 | 5.10 ± 10.10 |
| Gender | Male | 27% | 22% |
| Female | 73% | 78% |
List of medications and correspondence scores
| PHENOBARBITAL | 8 | −0.690 |
| CLOMIPRAMINE | 8 | −0.690 |
| METHADONE | 7 | −0.690 |
| IMIPRAMINE | 17 | −0.423 |
| MORPHINE | 36 | −0.423 |
| PRIMIDONE | 43 | −0.405 |
| HYDROCODONE | 46 | −0.262 |
| DIAZEPAM | 128 | −0.234 |
| CHLORDIAZEPOXIDE | 45 | −0.225 |
| RBAMAZEPINE | 37 | −0.187 |
| OXAZEPAM | 23 | −0.155 |
| MIRTAZAPINE | 86 | −0.124 |
| AMITRIPTYLINE | 180 | −0.095 |
| ALPRAZOLAM | 1297 | −0.094 |
| CLONAZEPAM | 368 | −0.077 |
| BUSPIRONE | 124 | −0.072 |
| OXYCODONE | 206 | −0.054 |
| GABAPENTIN | 210 | −0.051 |
| DIGOXIN | 272 | −0.038 |
| MEPROBAMATE | 44 | −0.010 |
| LORAZEPAM | 572 | 0.009 |
| DISOPYRAMIDE | 9 | 0.023 |
| NEFAZODONE | 6 | 0.023 |
| PHENYTOIN | 35 | 0.023 |
| TEMAZEPAM | 1470 | 0.030 |
| ESTAZOLAM | 179 | 0.045 |
| PAROXETINE | 338 | 0.049 |
| CHLORPROMAZINE | 11 | 0.165 |
| TRIAZOLAM | 16 | 0.227 |
| FLUOXETINE | 310 | 0.241 |
| BACLOFEN | 25 | 0.379 |
| DESIPRAMINE | 6 | 0.379 |
| HYDROMORPHONE | 7 | 0.379 |
| HALOPERIDOL | 11 | 0.379 |
| CITALOPRAM | 60 | 0.414 |
| TRAZODONE | 234 | 0.455 |
| BUPROPION | 20 | 0.498 |
| DOXEPIN | 83 | 0.580 |
| PERPHENAZINE | 19 | 0.593 |
| AMOXAPINE | 7 | 1.449 |
| THIORIDAZINE | 8 | 1.449 |
Figure 2Proposed fall model for the latent class analysis. This is a plot of the probability of falling by correspondence analysis derived drug score.
Basic latent class structure
| Pearson | 2519 | 2196 | 2173 | 2172 |
| LR | 1171 | 1156 | 1143 | 1107 |
| 478 | 469 | 462 | 454 | |
| Loglikelihood | −12922 | −12012 | −11672 | −11509 |
| Number of parameters | 48 | 61 | 74 | 87 |
| BIC | 24226 | 23893 | 23718 | 23710 |
| LMR ( | .000 | .029 | .758 | .626 |
| BLRT ( | .000 | .028 | .758 | .626 |
| Entropy | .854 | .883 | .893 | .839 |
Figure 3Overlay plot of latent classes by medical condition. Arthritis = Arthritis. HBP = High Blood Pressure. DB = Diabetes. HD = Heart Disease. FD = Foot Disorders. PD = Parkinson’s Disease. Stroke = Stroke.
Most likely latent class membership
| Class 1 | 477 | 17% | 0.95 | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 |
| Class 2 | 792 | 28% | 0.00 | 0.89 | 0.11 | 0.00 | 0.00 | 0.00 |
| Class 3 | 486 | 17% | 0.00 | 0.16 | 0.84 | 0.00 | 0.00 | 0.00 |
| Class 4 | 553 | 20% | 0.04 | 0.00 | 0.00 | 0.96 | 0.00 | 0.00 |
| Class 5 | 222 | 8% | 0.01 | 0.00 | 0.00 | 0.00 | 0.95 | 0.04 |
| Class 6 | 284 | 10% | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.97 |
| Total | 2,814 | 100% |
Most likely latent class membership
| Class 1 | .95 | .00 | .00 | .04 | .00 | .00 |
| Class 2 | .00 | .89 | .11 | .00 | .00 | .00 |
| Class 3 | .00 | .16 | .84 | .00 | .00 | .00 |
| Class 4 | .04 | .00 | .00 | .96 | .00 | .00 |
| Class 5 | .01 | .00 | .00 | .00 | .95 | .04 |
| Class 6 | .00 | .00 | .00 | .00 | .03 | .97 |
Odds ratios
| 6 | Vs | 1 | 4.41 | 0.000 | 3.07 | 6.46 |
| 6 | Vs | 2 | 4.67 | 0.000 | 3.32 | 6.72 |
| 6 | Vs | 3 | 1.12 | 0.574 | 0.75 | 1.69 |
| 6 | Vs | 4 | 2.07 | 0.000 | 1.43 | 3.04 |
| 6 | Vs | 5 | 2.24 | 0.000 | 1.45 | 3.49 |
Note: Base or comparison group is class six or the “healthy group II” group.